LeMaitre Vascular, Inc. (LMAT) stock analysis
LMAT · LeMaitre Vascular, Inc.
Latest recorded price: USD 77.01
Model-estimated fair value: USD 78.64. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Instruments & Supplies
At $77.01, LMAT trades 2.1% below the model's base-case value of $78.64. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $61.52 in the conservative case and $99.23 in the optimistic case, with a valuation confidence score of 60/100. Fiscal 2025 figures: revenue growth 15.6%, free cash flow margin 29.8%, ROIC 31.0%. The model does not flag any risk signals for this company.